Literature DB >> 21671057

Occurrence of lymph node metastasis in early-stage parotid gland cancer.

Markus Stenner1, Christoph Molls, Jan C Luers, Dirk Beutner, Jens P Klussmann, Karl-Bernd Huettenbrink.   

Abstract

Lymph node metastasis is one of the most important factors in therapy and prognosis for patients with parotid gland cancer. Nevertheless, the extent of the primary tumor resection and the necessity of a neck dissection still is a common issue. Since little is known about lymph node metastasis in early-stage parotid gland cancer, the purpose of the present study was to evaluate the occurrence of lymph node metastases in T1 and T2 carcinomas and its impact on local control and survival. We retrospectively analyzed 70 patients with early-stage (T1 and T2) primary parotid gland cancer. All patients were treated with parotidectomy and an ipsilateral neck dissection from 1987 to 2009. Clinicopathological and survival parameters were calculated. The median follow-up time was 51.7 months. A positive pathological lymph node stage (pN+) was found in 21.4% of patients with a significant correlation to the clinical lymph node stage (cN) (p = 0.061). There were no differences in the clinical and histopathological data between pN- and pN+ patients. In 73.3% of pN+ patients, the metastases were located intraparotideal. The incidence of occult metastases (pN+/cN-) was 17.2%. Of all patients with occult metastases, 30.0% had extraparotideal lymphatic spread. A positive lymph node stage significantly indicated a poorer 5-year overall as well as 5-year disease-free survival rate compared to pN- patients (p = 0.048; p = 0.011). We propose total parotidectomy in combination with at least a level II-III selective neck dissection in any case of early-stage parotid gland cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21671057     DOI: 10.1007/s00405-011-1663-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.

Authors:  Rohan R Walvekar; Pedro A Andrade Filho; Raja R Seethala; William E Gooding; Dwight E Heron; Jonas T Johnson; Robert L Ferris
Journal:  Head Neck       Date:  2011-02       Impact factor: 3.147

2.  Cytoplasmic expression of survivin is an independent predictor of poor prognosis in patients with salivary gland cancer.

Authors:  Markus Stenner; Antje Weinell; Tobias Ponert; Aline Hardt; Moritz Hahn; Simon F Preuss; Orlando Guntinas-Lichius; Jens Peter Klussmann
Journal:  Histopathology       Date:  2010-11       Impact factor: 5.087

3.  Determinants of survival in parotid gland carcinoma: a population-based study.

Authors:  Neil Bhattacharyya; Marvin P Fried
Journal:  Am J Otolaryngol       Date:  2005 Jan-Feb       Impact factor: 1.808

4.  Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival.

Authors:  Lena Cederblad; Silvia Johansson; Gunilla Enblad; Mats Engström; Erik Blomquist
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

5.  Predicting occult lymph node metastasis in parotid cancer.

Authors:  R A Frankenthaler; R M Byers; M A Luna; D L Callender; P Wolf; H Goepfert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1993-05

6.  Carcinoma of the parotid gland.

Authors:  Peter Zbären; Jonas Schüpbach; Michel Nuyens; Edouard Stauffer; Richard Greiner; Rudolf Häusler
Journal:  Am J Surg       Date:  2003-07       Impact factor: 2.565

7.  High incidence of lymph node metastasis in major salivary gland cancer.

Authors:  Eberhard Stennert; Dilek Kisner; Markus Jungehuelsing; Orlando Guntinas-Lichius; Ursula Schröder; Hans Edmund Eckel; Jens Peter Klussmann
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-07

8.  Prognostic index for patients with parotid carcinoma: international external validation in a Belgian-German database.

Authors:  Vincent Vander Poorten; Augustinus Hart; Tom Vauterin; Gert Jeunen; Joseph Schoenaers; Marc Hamoir; Alphonsus Balm; Eberhard Stennert; Orlando Guntinas-Lichius; Pierre Delaere
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

9.  The indications for elective treatment of the neck in cancer of the major salivary glands.

Authors:  J G Armstrong; L B Harrison; H T Thaler; H Friedlander-Klar; D E Fass; M J Zelefsky; J P Shah; E W Strong; R H Spiro
Journal:  Cancer       Date:  1992-02-01       Impact factor: 6.860

10.  Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland.

Authors:  José F Carrillo; Rafael Vázquez; Margarita C Ramírez-Ortega; Ana Cano; Francisco J Ochoa-Carrillo; Luis F Oñate-Ocaña
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

View more
  15 in total

1.  Elective neck dissection in adenoid cystic carcinoma of head and neck: yes or no? A systematic review.

Authors:  Ivica Luksic; Petar Suton
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-03       Impact factor: 2.503

2.  Primary parotid carcinoma: analysis of risk factors and validation of a prognostic index.

Authors:  Alberto Paderno; Michele Tomasoni; Davide Mattavelli; Simonetta Battocchio; Davide Lombardi; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-12       Impact factor: 2.503

3.  Metastasis of nasopharyngeal carcinoma to parotid lymph nodes: a retrospective study.

Authors:  Shengye Wang; Jianlin Lou; Suzhan Zhang; Liang Guo; Kejing Wang; Minghua Ge
Journal:  World J Surg Oncol       Date:  2015-01-26       Impact factor: 2.754

4.  Probability and pattern of occult cervical lymph node metastases in primary parotid carcinoma.

Authors:  Dominik Stodulski; Bogusław Mikaszewski; Hanna Majewska; Piotr Wiśniewski; Czesław Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-28       Impact factor: 2.503

Review 5.  Management of salivary gland carcinomas - a review.

Authors:  Xiaoli Wang; Yijun Luo; Minghuan Li; Hongjiang Yan; Mingping Sun; Tingyong Fan
Journal:  Oncotarget       Date:  2017-01-17

6.  Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients.

Authors:  Guangyan Cheng; Fei Liu; Xinyu Niu; Qigen Fang
Journal:  Cancer Manag Res       Date:  2019-03-21       Impact factor: 3.989

7.  Sentinel lymph node biopsy in cN0 neck management of parotid cancer.

Authors:  Wenting Pan; Kai Ba; Xingyu Niu; Fei Liu; Qigen Fang
Journal:  Sci Rep       Date:  2019-06-06       Impact factor: 4.379

8.  Patterns of treatment failure in salivary gland cancers.

Authors:  Mateusz Szewczyk; Paweł Golusiński; Jakub Pazdrowski; Piotr Pieńkowski; Sławomir Marszałek; Jacek Sygut; Wojciech Golusiński
Journal:  Rep Pract Oncol Radiother       Date:  2018-06-23

9.  The Clinical Characteristics and CT Findings of Parotid and Submandibular Gland Tumours.

Authors:  Houdong Zuo
Journal:  J Oncol       Date:  2021-07-03       Impact factor: 4.375

10.  Contemporary Management of Benign and Malignant Parotid Tumors.

Authors:  Jovanna Thielker; Maria Grosheva; Stephan Ihrler; Andrea Wittig; Orlando Guntinas-Lichius
Journal:  Front Surg       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.